Risk factors for hepatotoxicity in HIV-1-infected patients receiving ritonavir and saquinavir with or without stavudine

EH Gisolf, C Dreezen, SA Danner, JLF Weel, GJ Weverling, Group Prometheus Study

Research output: Contribution to journalA1: Web of Science-article

Original languageEnglish
JournalClinical Infectious Diseases
Volume31
Issue number5
Pages (from-to)1234-1239
ISSN1058-4838
DOIs
Publication statusPublished - 2000

Keywords

  • B780-tropical-medicine
  • Viral diseases
  • HIV-1
  • Drug therapy
  • Ritonavir
  • Saquinavir
  • Stavudine
  • Adverse effects
  • Liver

Cite this